Improving Diet Protein Intake in Middle-aged Women

December 7, 2020 updated by: Sareen Gropper, PhD, RDN, LDN, Florida Atlantic University
The study sought to examine the effectiveness of nutrition education with and without diet coaching on dietary protein intake and muscle mass, strength and function among a group of middle-aged women.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study sought to examine the effectiveness of nutrition education alone and with 10 weeks of diet coaching on dietary protein intake and muscle mass, strength and function among a group of middle-aged women.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Boca Raton, Florida, United States, 33431
        • Florida Atlantic University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • able to understand and respond to questions or instructions in English
  • working telephone
  • willingness to consume protein-containing animal products,
  • willingness to make changes to the diet

Exclusion Criteria:

  • self-reported information that they have been told by a medical doctor that they have kidney (renal) disease
  • current or past history of a diagnosed eating disorder
  • have an internal cardiac pacemaker/defibrillator or other metal-type implant present
  • vegan dietary practices
  • refusal to make changes to usual dietary protein intake
  • usual dietary protein intake greater than 1.2 g per kg body weight

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Coached
10 weeks of diet coaching
10-weeks of diet coaching weekly by telephone to improve dietary protein intake
No Intervention: Not-coached
No coaching provided

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in dietary protein intake from baseline
Time Frame: 12 weeks
Assessed changes in dietary protein intake from three 24-hour dietary recalls collected at baseline.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in muscle mass
Time Frame: 12 weeks
Changes in muscle mass from baseline were measured using bioelectrical impedance analysis
12 weeks
Changes in upper body muscle strength
Time Frame: 12 weeks
Changes in handgrip strength from baseline were measured using hand dynamometer
12 weeks
Changes in lower body muscle strength and function
Time Frame: 12 weeks
Changes in 5-chair stand times from baseline were assessed
12 weeks
Changes in muscle function
Time Frame: 12 weeks
Changes in 4 meter gait speed from baseline were assessed
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sareen S Gropper, PhD, Professor, College of Nursing, Florida Atlantic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 26, 2019

Primary Completion (Actual)

January 24, 2020

Study Completion (Actual)

January 24, 2020

Study Registration Dates

First Submitted

October 16, 2020

First Submitted That Met QC Criteria

December 7, 2020

First Posted (Actual)

December 9, 2020

Study Record Updates

Last Update Posted (Actual)

December 9, 2020

Last Update Submitted That Met QC Criteria

December 7, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1440147-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe